Form 8-K - Current report:
SEC Accession No. 0001410939-20-000034
Filing Date
2020-08-05
Accepted
2020-08-05 07:07:48
Documents
16
Period of Report
2020-08-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K isee-20200805.htm   iXBRL 8-K 42450
2 EX-99.1 ivericq2-2020earningsp.htm EX-99.1 114906
8 image011.jpg GRAPHIC 50717
  Complete submission text file 0001410939-20-000034.txt   384429

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT isee-20200805.xsd EX-101.SCH 2442
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT isee-20200805_cal.xml EX-101.CAL 727
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT isee-20200805_def.xml EX-101.DEF 1665
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT isee-20200805_lab.xml EX-101.LAB 25298
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT isee-20200805_pre.xml EX-101.PRE 13207
9 EXTRACTED XBRL INSTANCE DOCUMENT isee-20200805_htm.xml XML 10943
Mailing Address ONE PENN PLAZA 35TH FLOOR NEW YORK NY 10119
Business Address ONE PENN PLAZA 35TH FLOOR NEW YORK NY 10119 212-845-8200
IVERIC bio, Inc. (Filer) CIK: 0001410939 (see all company filings)

EIN.: 208185347 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36080 | Film No.: 201075594
SIC: 2834 Pharmaceutical Preparations